Tag: Merck

All

Merck’s COVID Drug May be Causing the Virus to Mutate

Researchers identified unusual COVID-19 mutation patterns that were strongly associated with molnupiravir use and coincided with the drug's introduction.

Ebola Vaccine Approved in Children Age 1 and Older
Gefapixant Gets European Medicines Agency’s Backing for Chronic Cough
FDA Green-lights Merck’s MMRV Vaccines for Intramuscular Injection
Merck’s Keytruda Meets Primary Endpoint in Phase 3 Trial for Lung Cancer
FDA Approves Vaxneuvance Pneumococcal Vaccine for Infants, Children
FDA Authorizes Merck Molnupiravir Antiviral COVID Pill
Merck VaxNeuvance Pneumococcal Vaccine Approved in EU

All

Success of COVID Antiviral Pills Hinges on Access to Speedy and Accurate Tests

Experts say the success of COVID Antiviral Pills depends on whether high-risk patients will be able to get tested, and then treated, fast enough to make a difference.

Merck to License COVID-19 Antiviral to Drugmakers in Other Companies
Merck’s COVID-19 Antiviral Pill Cut Prevented Mortality, Cut Hospitalization Risks in Half
FDA: New Merck Pneumonia Vaccine OK’d
Merk’s Experimental Lung Cancer Drug Fails Trial
Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate
Merck’s Sublingual Allergen Ragwitek Approved By FDA For Ragweed Allergies

All

FDA Approves Merck’s Sublingual Allergen Grastek

Sublingual allergen extract Grastek has received FDA approval as an immunotherapy for the treatment of Timothy grass pollen-induced allergic rhinitis.

Habitat for Humanity ‘Asthma-Healthy Home’ to be Dedicated
Merck Childhood Asthma Network Pledges Continued Support to Post-Katrina Children’s Asthma Management Program

Tag: Merck

All

All

All

Sorry, No Posts Found